Dacarbazine
- Product NDC
- 0703-5075
- 11-digit product format
- 007035075
- Labeler code
- 0703
- Product ID
- 0703-5075_eba1f8b2-278e-47f8-8e45-849d9d0bfcfc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Dacarbazine
- Dosage form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Teva Parenteral Medicines, Inc.
- Application
- ANDA075259
- Marketing category
- ANDA
- Marketing start
- 1998-08-27
- Marketing end
- 0000-00-00
- Substance
- DACARBAZINE
- Active strength
- 200 mg/20mL
- Pharmacologic classes
- Alkylating Activity [MoA], Alkylating Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0703-5075-01 | 00703507501 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0703-5075-01) > 20 mL in 1 VIAL, SINGLE-DOSE | 1998-08-27 | 0000-00-00 | No | No | Current |
| 0703-5075-03 | 00703507503 | 10 VIAL, SINGLE-DOSE in 1 TRAY (0703-5075-03) > 20 mL in 1 VIAL, SINGLE-DOSE | 1998-08-27 | 0000-00-00 | No | No | Current |